NIH National Library of Medicine
Ivermectin is a macrolide antiparasitic drug with a 16-membered ring that is widely used for the treatment of
many parasitic diseases such as river blindness, elephantiasis and scabies. Satoshi Omura and William C.
Campbell won the 2015 Nobel Prize in Physiology or Medicine for the discovery of the excellent efficacy of
ivermectin against parasitic diseases. Recently, ivermectin has been reported to inhibit the proliferation of
several tumor cells by regulating multiple signaling pathways. This suggests that ivermectin may be an anti-cancer drug with great potential…
Ivermectin cancer
Related articles:
Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-κB pathway
Ivermectin inhibits HSP27 and potentiates efficacy of oncogene targeting in tumor models
Ivermectin has New Application in Inhibiting Colorectal Cancer Cell Growth
Anti-parasite drug ivermectin can suppress ovarian cancer by regulating lncRNA-EIF4A3-mRNA axes